Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 2015. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding the GlaxoSmithKline Performance Share Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific equity transaction rather than general financial performance.
Material Changes
The filing details a transaction where American Depositary Shares (ADS) were withheld to meet tax liabilities following the vesting of a Performance Share Plan (PSP) award granted in 2012. The specific details are:
- Director: Dr M Slaoui
- Connected Person: Mrs K Slaoui
- Transaction Date: 5 March 2015
- Shares Withheld: 266 ADS
- Price per ADS: $47.82
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the routine tax withholding transaction described above.
Key Facts for Investor Verification
- Verify the total number of shares held by Dr M Slaoui and Mrs K Slaoui following the withholding of 266 ADS.
- Confirm the vesting schedule and performance metrics for the 2009 Performance Share Plan awards granted in 2012.
- Review the company's broader insider trading activity for the quarter to assess overall executive sentiment.